Global Cartilage Degeneration Market: Snapshot
Cartilage is a soft, rubbery material found in joints. The function of the cartilage is to avoid friction between bones; thus, it works as a shock absorber in the joint. Injury to the cartilage restricts the regular movement of the joint and can cause severe pain. If left untreated or if the injury is serious, it may require joint replacement surgery. Impairment to articular cartilage generally occurs after accidental injury or trauma to joints such as knees or hips. Cartilage degeneration may occur due to diseases such as arthritis and osteoarthritis as well.
Factors such as the increase in the global geriatric population, increase in the number of sports injuries, and rise in the obese population are key factors which drive the growth of cartilage degeneration market. However, increase in the cost of surgical treatment and devices and lack of reimbursement policies in emerging countries are some of the factors which may hinder the market growth.
According to Transparency Market Research, the global cartilage degeneration market was valued at US$9.5 bn in 2017 and is likely to reach US$14.7 bn by 2025. The market is expected to exhibit a strong 5.6% CAGR in the forecast period.
Joint Replacements Likely to Lead Demand from Cartilage Degeneration Market
The global cartilage degeneration market is classified by procedure type, application, and treatment delivery channel. By procedure type the market is categorized into joint replacements, chondroplasty, osteochondral transplants, micro-fracture, meniscus transplants, cell based cartilage resurfacing, autologous chondrocyte implantation (ACI), and others. By application, the cartilage degeneration market is divided into knees, hips, and others. By treatment delivery channel the market is classified into hospitals, academic and research institutes, specialty clinics, ambulatory surgical centers, and others.
By procedure type, joint replacements accounted for the largest share of the market in 2016. Following joint replacements, the chondroplasty segment accounted for a major share in the cartilage degeneration market in 2016. The key elements responsible for the growth of this market are the easy accessibility of the procedure in hospitals and diagnostic centers. Chondroplasty also takes less time for recovery in comparison with other traditional methods of surgery. Autologous chondrocyte implantation (ACI) is a comparatively new technology used for the treatment of isolated full-thickness articular cartilage imperfections of the knee.
By application, the knee surgery or repair market is anticipated to dominate the cartilage degeneration market in the near future. Knees are the largest joints in a human body. According to a report from the Centers for Disease Control and Prevention, in 2014, about 13% of women and 10% of men aged 60 years and older have indicative knee osteoarthritis symptoms. The growing prevalence of the disease is thus likely to drive the demand for knee surgeries in the coming years.
North America to Dominate Cartilage Degeneration Market due to Widespread Healthcare Infrastructure
Geographically, the global cartilage denegation market has been differentiated into the following regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the global market till 2025 due to the widespread access to satisfactory reimbursement policies due to the provision of the Affordable Care Act and increasing incidence of joint injuries. The North America market for cartilage degeneration was valued at US$3.9 bn in 2017 and is expected to rise to US$6.1 bn by 2025 at a stable CAGR of 5.7%.
Asia Pacific is projected to be a rapidly growing market for cartilage degeneration procedures during the forecast period due to robust economic growth in countries such as Australia, the Philippines, China, Singapore, India, and others. Furthermore, substantial growth in the geriatric population is anticipated to encourage the growth of the global cartilage degeneration market in the region. The Asia Pacific cartilage degeneration market is likely to exhibit a robust 6.1% CAGR between 2017 and 2025, rising from a valuation of US$1.9 bn to US$3.2 bn therein.
The global cartilage degeneration market includes key companies such as DePuy Synthes, Zimmer Biomet, Stryker Corporation, Smith & Nephew plc, and B. Braun Melsungen AG, among others.
The global cartilage degeneration market is segmented into the following categories:
|
by Procedure Type |
|
|
by Application |
|
|
by Treatment Delivery Channels |
|
|
by Geography |
|
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology
Section 3 Executive Summary
3.1 Market Introduction
3.2 Global Cartilage Degeneration Market Size ($ Mn) and Distribution, by Geography, 2017 and 2025
3.3 Global Cartilage Degeneration Market Size ($ Mn), by Procedure, 2017 and 2025
3.4 Global Cartilage Degeneration Market Size ($ Mn), by Application, 2017 and 2025
3.5 Global Cartilage Degeneration Market Size ($ Mn), by Treatment Delivery Channels, 2017 and 2025
Section 4 Market Overview
4.1 Overview
4.2 Recent Developments
4.3 Mergers & Acquisitions Update
4.4 Global Cartilage Degeneration Market Size (US$ Mn) Forecast, 2015–2025
Section 5 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunities
4.3 Global Cartilage Degeneration Market: Porter's Analysis
5.4 Cartilage Degeneration Market- Value Chain Analysis
5.5 Pipeline Analysis of Osteoarthritis Drugs
5.6 Randomized Clinical Trials (RCTs) for Cartilage Repair
5.7 Comparison between Percentage Distribution of Population Aged 65 and Over, by Region
5.8 Obesity Rates (%) of Total Adult Population in 2015
Section 6 Global Cartilage Degeneration Market Analysis, by Procedure
6.1 Key Findings
6.2 Introduction
6.3 Global Cartilage Degeneration Market Value Share Analysis, by Procedure Type
6.4 Global Cartilage Degeneration Market Attractiveness, by Procedure Type
6.5 Global Cartilage Degeneration Market Forecast, by Procedure Type
6.6 Global Cartilage Degeneration Market Analysis, by Procedure Type
6.7 Key Trends
Section 7 Global Cartilage Degeneration Market Analysis, by Application
7.1 Key Findings
7.2 Introduction
7.3 Global Cartilage Degeneration Market Value Share Analysis, by Application
7.4 Global Cartilage Degeneration Market Attractiveness, by Application
7.5 Global Cartilage Degeneration Market Forecast, by Application
7.6 Global Cartilage Degeneration Market Analysis, by Application
7.7 Key Trends
Section 8 Global Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
8.1 Key Findings
8.2 Introduction
8.3 Global Cartilage Degeneration Market Value Share Analysis, by Treatment Delivery Channel
8.4 Global Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel
8.5 Global Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
8.6 Global Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
8.7 Key Trends
Section 9 Global Cartilage Degeneration Market Analysis, by Region
9.1 Global Cartilage Degeneration Market Snapshot, by Country
9.2 Global Cartilage Degeneration Market Value Share Analysis, by Region
9.3 Cartilage Degeneration Market Forecast, by Region
9.4 Cartilage Degeneration Market Attractiveness Analysis, by Region
9.5 Key Findings
Section 10 North America Cartilage Degeneration Market Analysis
10.1 North America Cartilage Degeneration Market Overview
10.2 Market Value Share Analysis, by Country
10.3 North America Market Value Share Analysis, by Country
10.4 North America Cartilage Degeneration Market Forecast, by Country
10.5 North America Cartilage Degeneration Market Analysis, by Procedure
10.6 North America Cartilage Degeneration Market Attractiveness, by Procedure
10.7 North America Cartilage Degeneration Market Forecast, by Procedure
10.8 North America Cartilage Degeneration Market Analysis, by Application
10.9 North America Cartilage Degeneration Market Forecast, by Application
10.10 North America Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
10.11 North America Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
10.12 Market Trends
Section 11 Europe Cartilage Degeneration Market Analysis
11.1 Europe Cartilage Degeneration Market Overview
11.2 Market Value Share Analysis, by Country
11.3 Europe Market Value Share Analysis, by Country
11.4 Europe Cartilage Degeneration Market Forecast, by Country
11.5 Europe Cartilage Degeneration Market Analysis, by Procedure
11.6 Europe Cartilage Degeneration Market Attractiveness, by Procedure
11.7 Europe Cartilage Degeneration Market Forecast, by Procedure
11.8 Europe Cartilage Degeneration Market Analysis, by Application
11.9 Europe Cartilage Degeneration Market Forecast, by Application
11.10 Europe Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
11.11 Europe Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
11.12 Market Trends
Section 12 Asia Pacific Cartilage Degeneration Market Analysis
12.1 Asia Pacific Cartilage Degeneration Market Overview
12.2 Market Value Share Analysis, by Country
12.3 Asia Pacific Market Value Share Analysis, by Country
12.4 Asia Pacific Cartilage Degeneration Market Forecast, by Country
12.5 Asia Pacific Cartilage Degeneration Market Analysis, by Procedure
12.6 Asia Pacific Cartilage Degeneration Market Attractiveness, by Procedure
12.7 Asia Pacific Cartilage Degeneration Market Forecast, by Procedure
12.8 Asia Pacific Cartilage Degeneration Market Analysis, by Application
12.9 Asia Pacific Cartilage Degeneration Market Forecast, by Application
12.10 Asia Pacific Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
12.11 Asia Pacific Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
12.12 Market Trends
Section 13 Latin America Cartilage Degeneration Market Analysis
13.1 Latin America Cartilage Degeneration Market Overview
13.2 Market Value Share Analysis, by Country
13.3 Latin America Market Value Share Analysis, by Country
13.4 Latin America Cartilage Degeneration Market Forecast, by Country
13.5 Latin America Cartilage Degeneration Market Analysis, by Procedure
13.6 Latin America Cartilage Degeneration Market Attractiveness, by Procedure
13.7 Latin America Cartilage Degeneration Market Forecast, by Procedure
13.8 Latin America Cartilage Degeneration Market Analysis, by Application
13.9 Latin America Cartilage Degeneration Market Forecast, by Application
13.10 Latin America Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
13.11 Latin America Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
13.12 Market Trends
Section 14 Middle East & Africa Cartilage Degeneration Market Analysis
14.1 Middle East & Africa Cartilage Degeneration Market Overview
14.2 Market Value Share Analysis, by Country
14.3 Middle East & Africa Market Value Share Analysis, by Country
14.4 Middle East & Africa Cartilage Degeneration Market Forecast, by Country
14.5 Middle East & Africa Cartilage Degeneration Market Analysis, by Procedure
14.6 Middle East & Africa Cartilage Degeneration Market Attractiveness, by Procedure
14.7 Middle East & Africa Cartilage Degeneration Market Forecast, by Procedure
14.8 Middle East & Africa Cartilage Degeneration Market Analysis, by Application
14.9 Middle East & Africa Cartilage Degeneration Market Forecast, by Application
14.10 Middle East & Africa Cartilage Degeneration Market Analysis, by Treatment Delivery Channel
14.11 Middle East & Africa Cartilage Degeneration Market Forecast, by Treatment Delivery Channel
14.12 Market Trends
Section 15 Competition Landscape
15.1 Competition Matrix
15.2 Cartilage Degeneration Market Share Analysis
Section 16 Company Profiles
16.1 Zimmer Biomet Holdings, Inc.
16.1.1 Company Overview
16.1.2 Business Overview
16.1.3 Financial Overview
16.1.4 SWOT Analysis
16.1.5 Strategic Overview
16.2 Stryker Corporation
16.2.1 Company Overview
16.2.2 Business Overview
16.2.3 Financial Overview
16.2.4 SWOT Analysis
16.2.5 Strategic Overview
16.3 Smith & Nephew plc
16.3.1 Company Overview
16.3.2 Business Overview
16.3.3 Financial Overview
16.3.4 SWOT Analysis
16.3.5 Strategic Overview
16.4 B. Braun Melsungen AG
16.4.1 Company Overview
16.4.2 Business Overview
16.4.3 Financial Overview
16.4.4 SWOT Analysis
16.4.5 Strategic Overview
16.5 Medtronic plc
16.5.1 Company Overview
16.5.2 Business Overview
16.5.3 Financial Overview
16.5.4 SWOT Analysis
16.5.5 Strategic Overview
16.6 Johnson & Johnson (DePuy Synthes)
16.6.1 Company Overview
16.6.2 Business Overview
16.6.3 Financial Overview
16.6.4 SWOT Analysis
16.6.5 Strategic Overview
16.7 Osiris Therapeutics, Inc.
16.7.1 Company Overview
16.7.2 Business Overview
16.7.3 Financial Overview
16.7.4 SWOT Analysis
16.7.5 Strategic Overview
16.8 Vericel Corporation
16.8.1 Company Overview
16.8.2 Business Overview
16.8.3 Financial Overview
16.8.4 SWOT Analysis
16.8.5 Strategic Overview
16.9 Anika Therapeutics, Inc.
16.9.1 Company Overview
16.9.2 Business Overview
16.9.3 Financial Overview
16.9.4 SWOT Analysis
16.9.5 Strategic Overview
16.10 MEDIPOST Co., Ltd.
16.10.1 Company Overview
16.10.2 Business Overview
16.10.3 Financial Overview
16.10.4 SWOT Analysis
16.10.5 Strategic Overview
16.11 CONMED Corporation
16.11.1 Company Overview
16.11.2 Business Overview
16.11.3 Financial Overview
16.11.4 SWOT Analysis
16.11.5 Strategic Overview
16.12 Arthrex, Inc.
16.12.1 Company Overview
16.12.2 Business Overview
16.12.3 Financial Overview
16.12.4 SWOT Analysis
16.12.5 Strategic Overview
List of Tables
Table 01: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure Type, 2015–2025
Table 02: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 04: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 07: North America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 08: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 09: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 11: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 13: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 15: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 16: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channels, 2015–2025
Table 17: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 19: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 20: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 21: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Procedure, 2015–2025
Table 23: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) Forecast, by Treatment Delivery Channel, 2015–2025
Table 25: Business Overview Zimmer Biomet Holdings, Inc.
Table 26: Business Overview Stryker Corporation
Table 27: Business Overview Smith & Nephew plc
Table 28: Business Overview B. Braun Melsungen AG
Table 29: Business Overview Medtronic plc
Table 30: Business Overview Johnson & Johnson (DePuy Synthes)
Table 31: Business Overview Osiris Therapeutics, Inc.
Table 32: Business Overview Vericel Corporation
Table 33: Business Overview Anika Therapeutics, Inc.
Table 34: Business Overview MEDIPOST Co., Ltd.
Table 35: Business Overview CONMED Corporation
Table 36: Business Overview Arthrex, Inc.
List of Figures
Figure 01: Global Cartilage Degeneration Market Size ($ Mn) and Distribution, by Geography, 2017 and 2025
Figure 02: Global Cartilage Degeneration Market Size ($ Mn), by Procedure, 2017 and 2025
Figure 03: Global Cartilage Degeneration Market Size ($ Mn), by Application, 2017 and 2025
Figure 04: Global Cartilage Degeneration Market Size ($ Mn), By Treatment Delivery Channels, 2017 and 2025
Figure 05: Global Cartilage Degeneration Market Size (US$ Mn) Forecast, 2015–2025
Figure 06: Global Cartilage Degeneration Market Value Share, by Procedure Type, 2017 and 2025
Figure 07: Global Cartilage Degeneration Market Attractiveness, by Procedure Type, 2017–2025
Figure 08: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Joint Replacement, 2015–2025
Figure 09: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chondroplasty, 2015–2025
Figure 10: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Osteochondral Transplants, 2015–2025
Figure 11: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microfracture, 2015–2025
Figure 12: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Meniscus Transplant, 2015–2025
Figure 13: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell-based Cartilage Resurfacing, 2015–2025
Figure 14: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autologous Chondrocyte Implantation (ACI), 2015–2025
Figure 15: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 16: Global Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 17: Global Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 18: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Knee, 2015–2025
Figure 19: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hip, 2015–2025
Figure 20: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 21: Global Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 22: Global Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 23: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 24: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics & Research Institutes, 2015–2025
Figure 25: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2015–2025
Figure 26: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2015–2025
Figure 27: Global Cartilage Degeneration Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 28: Global Cartilage Degeneration Market Value Share, by Region, 2017 and 2025
Figure 29: Global Cartilage Degeneration Market Attractiveness, by Region, 2017–2025
Figure 30: North America Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 31: North America Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 32: North America Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 33: North America Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 34: North America Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 35: North America Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 36: North America Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 37: North America Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 38: North America Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 39: Europe Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 40: Europe Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 41: Europe Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 42: Europe Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 43: Europe Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 44: Europe Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 45: Europe Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 46: Europe Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 47: Europe Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 48: Asia Pacific Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
Figure 49: Asia Pacific Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 50: Asia Pacific Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 51: Asia Pacific Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 52: Asia Pacific Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 53: Asia Pacific Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 54: Asia Pacific Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 55: Asia Pacific Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 56: Asia Pacific Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 57: Latin America Cartilage Degeneration Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 58: Latin America Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 59: Latin America Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 60: Latin America Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 61: Latin America Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 62: Latin America Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 63: Latin America Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 64: Latin America Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 65: Latin America Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 66: Middle East & Africa Cartilage Degeneration Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 67: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Country, 2017–2025
Figure 68: Middle East & Africa Cartilage Degeneration Market Value Share Analysis, by Country, 2017 and 2025
Figure 69: Middle East & Africa Cartilage Degeneration Market Value Share, by Procedure, 2017 and 2025
Figure 70: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Procedure, 2017–2025
Figure 71: Middle East & Africa Cartilage Degeneration Market Value Share, by Application, 2017 and 2025
Figure 72: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Application, 2017–2025
Figure 73: Middle East & Africa Cartilage Degeneration Market Value Share, by Treatment Delivery Channel, 2017 and 2025
Figure 74: Middle East & Africa Cartilage Degeneration Market Attractiveness, by Treatment Delivery Channel, 2017–2025
Figure 75: Cartilage Degeneration Market Share Analysis of Companies, (Estimation)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cartilage Degeneration Market
*86 figures and 60 tables includes